< 0 1 0 1 O
18 1 3 1 3 B-upper_bound
years 4 9 4 9 I-upper_bound
of 10 12 10 12 O
age 13 16 13 16 B-age

Active 0 6 17 23 O
central 7 14 24 31 O
nervous 15 22 32 39 O
system 23 29 40 46 O
( 30 31 47 48 O
CNS 31 34 48 51 O
) 34 35 51 52 O
leukemia 36 44 53 61 B-cancer
, 44 45 61 62 O
as 46 48 63 65 O
defined 49 56 66 73 O
by 57 59 74 76 O
unequivocal 60 71 77 88 O
morphologic 72 83 89 100 O
evidence 84 92 101 109 O
of 93 95 110 112 O
lymphoblasts 96 108 113 125 O
in 109 111 126 128 O
the 112 115 129 132 O
cerebrospinal 116 129 133 146 O
fluid 130 135 147 152 O
( 136 137 153 154 O
CSF 137 140 154 157 O
) 140 141 157 158 O
or 142 144 159 161 O
symptomatic 145 156 162 173 O
CNS 157 160 174 177 O
leukemia 161 169 178 186 O
( 170 171 187 188 O
i.e. 171 175 188 192 O
cranial 176 183 193 200 B-chronic_disease
nerve 184 189 201 206 I-chronic_disease
palsies 190 197 207 214 I-chronic_disease
or 198 200 215 217 O
other 201 206 218 223 O
significant 207 218 224 235 O
neurologic 219 229 236 246 B-chronic_disease
dysfunction 230 241 247 258 I-chronic_disease
) 241 242 258 259 O
within 243 249 260 266 O
28 250 252 267 269 B-upper_bound
days 253 257 270 274 I-upper_bound
of 258 260 275 277 O
treatment 261 270 278 287 B-treatment

CBC 0 3 288 291 B-clinical_variable
within 4 10 292 298 O
one 11 14 299 302 B-upper_bound
week 15 19 303 307 I-upper_bound
of 20 22 308 310 O
donation 23 31 311 319 O

Cytopenias 0 10 320 330 B-chronic_disease
deemed 11 17 331 337 O
to 18 20 338 340 O
be 21 23 341 343 O
disease 24 31 344 351 O
- 31 32 351 352 O
related 32 39 352 359 O
and 40 43 360 363 O
not 44 47 364 367 O
therapy 48 55 368 375 O
- 55 56 375 376 O
related 56 63 376 383 O

Donor 0 5 384 389 O
's 5 7 389 391 O
high 8 12 392 396 O
resolution 13 23 397 407 O
HLA 24 27 408 411 B-treatment
typing 28 34 412 418 I-treatment
must 35 39 419 423 O
be 40 42 424 426 O
available 43 52 427 436 O
for 53 56 437 440 O
review 57 63 441 447 O

Evidence 0 8 448 456 O
of 9 11 457 459 O
prior 12 17 460 465 B-treatment
sensitization 18 31 466 479 I-treatment
to 32 34 480 482 O
EBV 35 38 483 486 B-chronic_disease
by 39 41 487 489 O
EBV 42 45 490 493 O
serology 46 54 494 502 O
testing 55 62 503 510 O
( 63 64 511 512 O
seropositive 64 76 512 524 O
) 76 77 524 525 O

Females 0 7 526 533 B-gender
who 8 11 534 537 O
are 12 15 538 541 B-pregnancy
pregnant 16 24 542 550 I-pregnancy

History 0 7 551 558 O
of 8 10 559 561 O
CD19 11 15 562 566 B-cancer
+ 15 16 566 567 I-cancer
malignancy 17 27 568 578 I-cancer
with 28 32 579 583 O
evidence 33 41 584 592 O
of 42 44 593 595 O
relapse 45 52 596 603 O
or 53 55 604 606 O
persistent 56 66 607 617 O
MRD 67 70 618 621 B-cancer
following 71 80 622 631 O
autologous 81 91 632 642 O
or 92 94 643 645 O
allogenic 95 104 646 655 O
hematopoietic 105 118 656 669 B-treatment
stem 119 123 670 674 I-treatment
cell 124 128 675 679 I-treatment
transplantation 129 144 680 695 I-treatment

History 0 7 696 703 O
of 8 10 704 706 O
clinically 11 21 707 717 O
significant 22 33 718 729 O
ventricular 34 45 730 741 B-chronic_disease
arrhythmia 46 56 742 752 I-chronic_disease
or 57 59 753 755 O
unexplained 60 71 756 767 B-chronic_disease
syncope 72 79 768 775 I-chronic_disease
, 79 80 775 776 O
not 81 84 777 780 O
believed 85 93 781 789 O
to 94 96 790 792 O
be 97 99 793 795 O
vasovagal 100 109 796 805 B-chronic_disease
in 110 112 806 808 O
nature 113 119 809 815 O
or 120 122 816 818 O
due 123 126 819 822 O
to 127 129 823 825 O
dehydration 130 141 826 837 B-chronic_disease

History 0 7 838 845 O
of 8 10 846 848 O
relapsed 11 19 849 857 O
or 20 22 858 860 O
refractory 23 33 861 871 O
CD19 34 38 872 876 O
+ 38 39 876 877 O
malignancies 40 52 878 890 B-cancer
( 53 54 891 892 O
e.g. 54 58 892 896 O
Non 59 62 897 900 B-cancer
Hodgkin 63 70 901 908 I-cancer
Lymphoma 71 79 909 917 I-cancer
) 79 80 917 918 O
who 81 84 919 922 O
have 85 89 923 927 O
failed 90 96 928 934 O
prior 97 102 935 940 B-treatment
treatment 103 112 941 950 I-treatment
and 113 116 951 954 O
require 117 124 955 962 O
autologous 125 135 963 973 O
hematopoietic 136 149 974 987 B-treatment
stem 150 154 988 992 I-treatment
cell 155 159 993 997 I-treatment
transplant 160 170 998 1008 I-treatment

History 0 7 1009 1016 O
of 8 10 1017 1019 O
severe 11 17 1020 1026 O
non 18 21 1027 1030 B-chronic_disease
- 21 22 1030 1031 I-chronic_disease
ischemic 22 30 1031 1039 I-chronic_disease
cardiomyopathy 31 45 1040 1054 I-chronic_disease
with 46 50 1055 1059 O
EF 51 53 1060 1062 B-clinical_variable
≤20 54 57 1063 1066 O
% 57 58 1066 1067 I-upper_bound

However 0 7 1068 1075 O
, 7 8 1075 1076 O
the 9 12 1077 1080 O
minimum 13 20 1081 1088 O
age 21 24 1089 1092 B-age
for 25 28 1093 1096 O
a 29 30 1097 1098 O
related 31 38 1099 1106 O
donor 39 44 1107 1112 O
is 45 47 1113 1115 O
7 48 49 1116 1117 B-lower_bound
years 50 55 1118 1123 I-lower_bound
as 56 58 1124 1126 O
this 59 63 1127 1131 O
is 64 66 1132 1134 O
the 67 70 1135 1138 O
youngest 71 79 1139 1147 O
age 80 83 1148 1151 O
a 84 85 1152 1153 O
person 86 92 1154 1160 O
can 93 96 1161 1164 O
be 97 99 1165 1167 O
considered 100 110 1168 1178 O
capable 111 118 1179 1186 O
of 119 121 1187 1189 O
giving 122 128 1190 1196 O
assent 129 135 1197 1203 O
to 136 138 1204 1206 O
participate 139 150 1207 1218 O
in 151 153 1219 1221 O
a 154 155 1222 1223 O
research 156 164 1224 1232 O
study 165 170 1233 1238 O

KPS 0 3 1239 1242 B-clinical_variable
or 4 6 1243 1245 O
Lansky 7 13 1246 1252 B-clinical_variable
score 14 19 1253 1258 I-clinical_variable
> 20 21 1259 1260 O
or 22 24 1261 1263 O
= 25 26 1264 1265 O
to 27 29 1266 1268 O
50 30 32 1269 1271 B-lower_bound

Myocardial 0 10 1272 1282 B-chronic_disease
infarction 11 21 1283 1293 I-chronic_disease
≤ 22 23 1294 1295 O
6months 24 31 1296 1303 B-upper_bound
prior 32 37 1304 1309 O
to 38 40 1310 1312 O
enrollment 41 51 1313 1323 O

New 0 3 1324 1327 B-clinical_variable
York 4 8 1328 1332 I-clinical_variable
Heart 9 14 1333 1338 I-clinical_variable
Association 15 26 1339 1350 I-clinical_variable
( 27 28 1351 1352 I-clinical_variable
NYHA 28 32 1352 1356 I-clinical_variable
) 32 33 1356 1357 I-clinical_variable
stage 34 39 1358 1363 B-lower_bound
III 40 43 1364 1367 I-lower_bound
or 44 46 1368 1370 O
IV 47 49 1371 1373 B-upper_bound
congestive 50 60 1374 1384 B-chronic_disease
heart 61 66 1385 1390 I-chronic_disease
failure 67 74 1391 1398 I-chronic_disease

No 0 2 1399 1401 O
age 3 6 1402 1405 B-age
restriction 7 18 1406 1417 O
for 19 22 1418 1421 O
patients 23 31 1422 1430 O

Patients 0 8 1431 1439 O
will 9 13 1440 1444 O
be 14 16 1445 1447 O
excluded 17 25 1448 1456 O
if 26 28 1457 1459 O
they 29 33 1460 1464 O
have 34 38 1465 1469 O
isolated 39 47 1470 1478 O
extra 48 53 1479 1484 O
- 53 54 1484 1485 O
medullary 54 63 1485 1494 O
relapse 64 71 1495 1502 O
of 72 74 1503 1505 O
ALL 75 78 1506 1509 B-cancer

Patients 0 8 1510 1518 O
with 9 13 1519 1523 O
active 14 20 1524 1530 O
( 21 22 1531 1532 O
grade 22 27 1532 1537 B-lower_bound
2 28 29 1538 1539 I-lower_bound
- 29 30 1539 1540 O
4 30 31 1540 1541 B-upper_bound
) 31 32 1541 1542 O
acute 33 38 1543 1548 B-chronic_disease
graft 39 44 1549 1554 I-chronic_disease
versus 45 51 1555 1561 I-chronic_disease
host 52 56 1562 1566 I-chronic_disease
disease 57 64 1567 1574 I-chronic_disease
( 65 66 1575 1576 I-chronic_disease
GVHD 66 70 1576 1580 I-chronic_disease
) 70 71 1580 1581 I-chronic_disease
, 71 72 1581 1582 O
chronic 73 80 1583 1590 B-chronic_disease
GVHD 81 85 1591 1595 I-chronic_disease
or 86 88 1596 1598 O
an 89 91 1599 1601 O
overt 92 97 1602 1607 B-chronic_disease
autoimmune 98 108 1608 1618 I-chronic_disease
disease 109 116 1619 1626 I-chronic_disease
( 117 118 1627 1628 O
e.g. 118 122 1628 1632 O
hemolytic 123 132 1633 1642 B-chronic_disease
anemia 133 139 1643 1649 I-chronic_disease
) 139 140 1649 1650 O
requiring 141 150 1651 1660 O
glucocorticosteroid 151 170 1661 1680 B-treatment
treatment 171 180 1681 1690 I-treatment
( 181 182 1691 1692 O
> 182 183 1692 1693 O
0.5 183 186 1693 1696 B-lower_bound
mg 187 189 1697 1699 I-lower_bound
/ 189 190 1699 1700 I-lower_bound
kg 190 192 1700 1702 I-lower_bound
/ 192 193 1702 1703 I-lower_bound
day 193 196 1703 1706 I-lower_bound
prednisone 197 207 1707 1717 B-treatment
or 208 210 1718 1720 O
its 211 214 1721 1724 O
equivalent 215 225 1725 1735 O
) 225 226 1735 1736 O
as 227 229 1737 1739 O
treatment 230 239 1740 1749 O

Patients 0 8 1750 1758 O
with 9 13 1759 1763 O
active 14 20 1764 1770 O
HIV 21 24 1771 1774 B-chronic_disease
, 24 25 1774 1775 O
hepatitis 26 35 1776 1785 B-chronic_disease
B 36 37 1786 1787 I-chronic_disease
or 38 40 1788 1790 I-chronic_disease
hepatitis 41 50 1791 1800 I-chronic_disease
C 51 52 1801 1802 I-chronic_disease
infection 53 62 1803 1812 I-chronic_disease

Patients 0 8 1813 1821 O
with 9 13 1822 1826 O
any 14 17 1827 1830 O
concurrent 18 28 1831 1841 O
active 29 35 1842 1848 O
malignancies 36 48 1849 1861 B-cancer
as 49 51 1862 1864 O
defined 52 59 1865 1872 O
by 60 62 1873 1875 O
malignancies 63 75 1876 1888 O
requiring 76 85 1889 1898 O
any 86 89 1899 1902 O
therapy 90 97 1903 1910 B-treatment
other 98 103 1911 1916 O
than 104 108 1917 1921 O
expectant 109 118 1922 1931 O
observation 119 130 1932 1943 O

Persistent 0 10 1944 1954 O
minimal 11 18 1955 1962 O
residual 19 27 1963 1971 B-cancer
disease 28 35 1972 1979 I-cancer
after 36 41 1980 1985 O
transplantation 42 57 1986 2001 B-treatment
must 58 62 2002 2006 O
be 63 65 2007 2009 O
demonstrated 66 78 2010 2022 O
by 79 81 2023 2025 O
morphology 82 92 2026 2036 B-treatment
karyotype 93 102 2037 2046 I-treatment
, 102 103 2046 2047 O
FISH 104 108 2048 2052 B-treatment
, 108 109 2052 2053 O
flow 110 114 2054 2058 B-treatment
cytometry 115 124 2059 2068 I-treatment
or 125 127 2069 2071 O
RT 128 130 2072 2074 B-treatment
- 130 131 2074 2075 I-treatment
PCR 131 134 2075 2078 I-treatment

Preceding 0 9 2079 2088 O
and/or 10 16 2089 2095 O
ongoing 17 24 2096 2103 O
organ 25 30 2104 2109 B-chronic_disease
dysfunction 31 42 2110 2121 I-chronic_disease
or 43 45 2122 2124 O
other 46 51 2125 2130 O
co 52 54 2131 2133 O
- 54 55 2133 2134 O
morbidity 55 64 2134 2143 O
including 65 74 2144 2153 O
but 75 78 2154 2157 O
not 79 82 2158 2161 O
limited 83 90 2162 2169 O
to 91 93 2170 2172 O
uncontrolled 94 106 2173 2185 B-chronic_disease
infection 107 116 2186 2195 I-chronic_disease
that 117 121 2196 2200 O
would 122 127 2201 2206 O
impair 128 134 2207 2213 O
the 135 138 2214 2217 O
patient 139 146 2218 2225 O
's 146 148 2225 2227 O
ability 149 156 2228 2235 O
to 157 159 2236 2238 O
endure 160 166 2239 2245 O
known 167 172 2246 2251 O
side 173 177 2252 2256 O
effects 178 185 2257 2264 O
of 186 188 2265 2267 O
cytokine 189 197 2268 2276 B-chronic_disease
release 198 205 2277 2284 I-chronic_disease
syndrome 206 214 2285 2293 I-chronic_disease
or 215 217 2294 2296 O
neurological 218 230 2297 2309 O
toxicity 231 239 2310 2318 O

Previous 0 8 2319 2327 B-treatment
infusion 9 17 2328 2336 I-treatment
of 18 20 2337 2339 I-treatment
CD19 21 25 2340 2344 I-treatment
CAR 26 29 2345 2348 I-treatment
T 30 31 2349 2350 I-treatment
cells 32 37 2351 2356 I-treatment
at 38 40 2357 2359 O
another 41 48 2360 2367 O
institution 49 60 2368 2379 O

Prior 0 5 2380 2385 O
neurologic 6 16 2386 2396 B-chronic_disease
toxicity 17 25 2397 2405 O
to 26 28 2406 2408 O
previous 29 37 2409 2417 B-treatment
immunotherapy 38 51 2418 2431 I-treatment

Rapidly 0 7 2432 2439 O
progressive 8 19 2440 2451 B-chronic_disease
disease 20 27 2452 2459 I-chronic_disease
that 28 32 2460 2464 O
in 33 35 2465 2467 O
the 36 39 2468 2471 O
estimation 40 50 2472 2482 O
of 51 53 2483 2485 O
the 54 57 2486 2489 O
treating 58 66 2490 2498 O
physician 67 76 2499 2508 O
would 77 82 2509 2514 O
compromise 83 93 2515 2525 O
ability 94 101 2526 2533 O
to 102 104 2534 2536 O
complete 105 113 2537 2545 O
study 114 119 2546 2551 O
therapy 120 127 2552 2559 B-treatment

Recent 0 6 2560 2566 O
prior 7 12 2567 2572 B-treatment
therapy 13 20 2573 2580 I-treatment
: 20 21 2580 2581 O
Systematic 22 32 2582 2592 B-treatment
chemotherapy 33 45 2593 2605 I-treatment
less 46 50 2606 2610 O
than 51 55 2611 2615 O
2 56 57 2616 2617 B-upper_bound
weeks 58 63 2618 2623 I-upper_bound
prior 64 69 2624 2629 I-upper_bound
to 70 72 2630 2632 O
infusion 73 81 2633 2641 B-treatment

Relapse 0 7 2642 2649 O
on 8 10 2650 2652 O
this 11 15 2653 2657 O
protocol 16 24 2658 2666 O
is 25 27 2667 2669 O
detection 28 37 2670 2679 O
of 38 40 2680 2682 O
CD19 41 45 2683 2687 O
+ 45 46 2687 2688 O
malignancies 47 59 2689 2701 B-cancer
in 60 62 2702 2704 O
bone 63 67 2705 2709 O
marrow 68 74 2710 2716 O
≥ 75 76 2717 2718 O
5 77 78 2719 2720 B-lower_bound
% 78 79 2720 2721 I-lower_bound
or 80 82 2722 2724 O
extramedullary 83 97 2725 2739 O
lesion 98 104 2740 2746 O
by 105 107 2747 2749 O
morphology 108 118 2750 2760 B-treatment
cytogenetics 119 131 2761 2773 I-treatment
, 131 132 2773 2774 O
molecular 133 142 2775 2784 B-treatment
, 142 143 2784 2785 O
radiographic 144 156 2786 2798 B-treatment
and/or 157 163 2799 2805 O
flow 164 168 2806 2810 B-treatment
cytometry 169 178 2811 2820 I-treatment

Renal 0 5 2821 2826 B-chronic_disease
function 6 14 2827 2835 I-chronic_disease
( 15 16 2836 2837 O
measured 16 24 2837 2845 O
prior 25 30 2846 2851 O
to 31 33 2852 2854 O
conditioning 34 46 2855 2867 O
chemotherapy 47 59 2868 2880 B-treatment
) 59 60 2880 2881 O

Results 0 7 2882 2889 O
of 8 10 2890 2892 O
tests 11 16 2893 2898 O
must 17 21 2899 2903 O
be 22 24 2904 2906 O
within 25 31 2907 2913 O
a 32 33 2914 2915 O
range 34 39 2916 2921 O
that 40 44 2922 2926 O
would 45 50 2927 2932 O
not 51 54 2933 2936 O
preclude 55 63 2937 2945 O
donating 64 72 2946 2954 O
blood 73 78 2955 2960 O
or 79 81 2961 2963 O
undergoing 82 92 2964 2974 O
leukapheresis 93 106 2975 2988 B-treatment

Serologic 0 9 2989 2998 B-treatment
testing 10 17 2999 3006 I-treatment
for 18 21 3007 3010 O
transmissible 22 35 3011 3024 O
diseases 36 44 3025 3033 O
will 45 49 3034 3038 O
be 50 52 3039 3041 O
performed 53 62 3042 3051 O
as 63 65 3052 3054 O
per 66 69 3055 3058 O
institutional 70 83 3059 3072 O
guidelines 84 94 3073 3083 O
adopted 95 102 3084 3091 O
from 103 107 3092 3096 O
extant 108 114 3097 3103 O
NMDP 115 119 3104 3108 O
and 120 123 3109 3112 O
FACT 124 128 3113 3117 O
guidelines 129 139 3118 3128 O
. 139 140 3128 3129 O
Donors 141 147 3130 3136 O
should 148 154 3137 3143 O
be 155 157 3144 3146 O
considered 158 168 3147 3157 O
eligible 169 177 3158 3166 O
to 178 180 3167 3169 O
donate 181 187 3170 3176 O
leukapheresis 188 201 3177 3190 B-treatment
or 202 204 3191 3193 O
blood 205 210 3194 3199 O
based 211 216 3200 3205 O
on 217 219 3206 3208 O
these 220 225 3209 3214 O
guidelines 226 236 3215 3225 O

Subjects 0 8 3226 3234 O
must 9 13 3235 3239 O
have 14 18 3240 3244 O
recovered 19 28 3245 3254 O
from 29 33 3255 3259 O
the 34 37 3260 3263 O
acute 38 43 3264 3269 O
side 44 48 3270 3274 O
effects 49 56 3275 3282 O
of 57 59 3283 3285 O
their 60 65 3286 3291 O
prior 66 71 3292 3297 B-treatment
therapy 72 79 3298 3305 I-treatment
, 79 80 3305 3306 O
such 81 85 3307 3311 O
that 86 90 3312 3316 O
eligibility 91 102 3317 3328 O
criteria 103 111 3329 3337 O
are 112 115 3338 3341 O
met 116 119 3342 3345 O

Subjects 0 8 3346 3354 O
receiving 9 18 3355 3364 O
hydroxyurea 19 30 3365 3376 B-treatment
or 31 33 3377 3379 O
oral 34 38 3380 3384 B-treatment
maintenance 39 50 3385 3396 I-treatment
chemotherapy 51 63 3397 3409 I-treatment
may 64 67 3410 3413 O
be 68 70 3414 3416 O
enrolled 71 79 3417 3425 O
provided 80 88 3426 3434 O
there 89 94 3435 3440 O
has 95 98 3441 3444 O
been 99 103 3445 3449 O
no 104 106 3450 3452 O
increase 107 115 3453 3461 O
in 116 118 3462 3464 O
dose 119 123 3465 3469 O
for 124 127 3470 3473 O
at 128 130 3474 3476 O
least 131 136 3477 3482 O
2 137 138 3483 3484 B-lower_bound
weeks 139 144 3485 3490 I-lower_bound
prior 145 150 3491 3496 I-lower_bound
to 151 153 3497 3499 O
starting 154 162 3500 3508 O
apheresis 163 172 3509 3518 B-treatment
or 173 175 3519 3521 O
treatment 176 185 3522 3531 B-treatment

Subjects 0 8 3532 3540 O
receiving 9 18 3541 3550 O
steroid 19 26 3551 3558 B-treatment
therapy 27 34 3559 3566 I-treatment
at 35 37 3567 3569 O
physiological 38 51 3570 3583 B-treatment
replacement 52 63 3584 3595 I-treatment
doses 64 69 3596 3601 O
only 70 74 3602 3606 O
are 75 78 3607 3610 O
allowed 79 86 3611 3618 O
provided 87 95 3619 3627 O
there 96 101 3628 3633 O
has 102 105 3634 3637 O
been 106 110 3638 3642 O
no 111 113 3643 3645 O
increase 114 122 3646 3654 O
in 123 125 3655 3657 O
dose 126 130 3658 3662 O
for 131 134 3663 3666 O
at 135 137 3667 3669 O
least 138 143 3670 3675 O
2 144 145 3676 3677 B-lower_bound
weeks 146 151 3678 3683 I-lower_bound
prior 152 157 3684 3689 I-lower_bound
to 158 160 3690 3692 O
subject 161 168 3693 3700 O
starting 169 177 3701 3709 O
apheresis 178 187 3710 3719 B-treatment
or 188 190 3720 3722 O
treatment 191 200 3723 3732 B-treatment

The 0 3 3733 3736 O
patient 4 11 3737 3744 O
's 11 13 3744 3746 O
HSCT 14 18 3747 3751 B-treatment
donor 19 24 3752 3757 O
, 24 25 3757 3758 O
or 26 28 3759 3761 O
if 29 31 3762 3764 O
HSCT 32 36 3765 3769 O
donor 37 42 3770 3775 O
is 43 45 3776 3778 O
not 46 49 3779 3782 O
available 50 59 3783 3792 O
a 60 61 3793 3794 O
third 62 67 3795 3800 O
party 68 73 3801 3806 O
donor 74 79 3807 3812 O
, 79 80 3812 3813 O
must 81 85 3814 3818 O
consent 86 93 3819 3826 O
to 94 96 3827 3829 O
a 97 98 3830 3831 O
leukapheresis 99 112 3832 3845 B-treatment
or 113 115 3846 3848 O
whole 116 121 3849 3854 O
blood 122 127 3855 3860 O
donation(s 128 138 3861 3871 O
) 138 139 3871 3872 O
obtained 140 148 3873 3881 O
at 149 151 3882 3884 O
one 152 155 3885 3888 O
or 156 158 3889 3891 O
more 159 163 3892 3896 O
phlebotomies 164 176 3897 3909 B-treatment
which 177 182 3910 3915 O
, 182 183 3915 3916 O
in 184 186 3917 3919 O
aggregate 187 196 3920 3929 O
, 196 197 3929 3930 O
will 198 202 3931 3935 O
total 203 208 3936 3941 O
approximately 209 222 3942 3955 O
250 223 226 3956 3959 O
ml 227 229 3960 3962 O
for 230 233 3963 3966 O
adults 234 240 3967 3973 O
and 241 244 3974 3977 O
no 245 247 3978 3980 O
more 248 252 3981 3985 O
than 253 257 3986 3990 O
5ml 258 261 3991 3994 B-lower_bound
/ 261 262 3994 3995 I-lower_bound
kg 262 264 3995 3997 I-lower_bound
per 265 268 3998 4001 O
draw 269 273 4002 4006 O
from 274 278 4007 4011 O
pediatric 279 288 4012 4021 O
donors 289 295 4022 4028 O

There 0 5 4029 4034 O
is 6 8 4035 4037 O
no 9 11 4038 4040 O
time 12 16 4041 4045 O
restriction 17 28 4046 4057 O
in 29 31 4058 4060 O
regard 32 38 4061 4067 O
to 39 41 4068 4070 O
prior 42 47 4071 4076 B-treatment
intrathecal 48 59 4077 4088 I-treatment
chemotherapy 60 72 4089 4101 I-treatment
provided 73 81 4102 4110 O
tere 82 86 4111 4115 O
is 87 89 4116 4118 O
complete 90 98 4119 4127 O
recovery 99 107 4128 4136 O
from 108 112 4137 4141 O
any 113 116 4142 4145 O
acute 117 122 4146 4151 O
toxic 123 128 4152 4157 O
effects 129 136 4158 4165 O
of 137 139 4166 4168 O
such 140 144 4169 4173 O

There 0 5 4174 4179 O
is 6 8 4180 4182 O
no 9 11 4183 4185 O
upper 12 17 4186 4191 O
age 18 21 4192 4195 B-age
limit 22 27 4196 4201 O
for 28 31 4202 4205 O
a 32 33 4206 4207 O
donors 34 40 4208 4214 O

Uncontrolled 0 12 4215 4227 O
, 12 13 4227 4228 O
symptomatic 14 25 4229 4240 O
, 25 26 4240 4241 O
intercurrent 27 39 4242 4254 O
illness 40 47 4255 4262 O
including 48 57 4263 4272 O
but 58 61 4273 4276 O
not 62 65 4277 4280 O
limited 66 73 4281 4288 O
to 74 76 4289 4291 O
infection 77 86 4292 4301 O
, 86 87 4301 4302 O
psychiatric 88 99 4303 4314 B-chronic_disease
illness 100 107 4315 4322 I-chronic_disease
, 107 108 4322 4323 O
or 109 111 4324 4326 O
social 112 118 4327 4333 B-chronic_disease
situations 119 129 4334 4344 I-chronic_disease
that 130 134 4345 4349 O
would 135 140 4350 4355 O
limit 141 146 4356 4361 O
compliance 147 157 4362 4372 O
with 158 162 4373 4377 O
study 163 168 4378 4383 O
requirements 169 181 4384 4396 O
or 182 184 4397 4399 O
in 185 187 4400 4402 O
the 188 191 4403 4406 O
opinion 192 199 4407 4414 O
of 200 202 4415 4417 O
the 203 206 4418 4421 O
treating 207 215 4422 4430 O
investigator 216 228 4431 4443 O
would 229 234 4444 4449 O
pose 235 239 4450 4454 O
an 240 242 4455 4457 O
unacceptable 243 255 4458 4470 O
risk 256 260 4471 4475 O
to 261 263 4476 4478 O
the 264 267 4479 4482 O
subject 268 275 4483 4490 O

cardiac 0 7 4491 4498 B-chronic_disease
conditions 8 18 4499 4509 I-chronic_disease

≥18 0 3 4510 4513 O
years 4 9 4514 4519 I-lower_bound
old 10 13 4520 4523 O
) 13 14 4523 4524 O

